Exxaro Resources Limited
Group and company annual financial statements for the year ended 31 December 2024 
1Chapter
2Chapter
3Chapter
4Chapter
5Chapter
6Chapter
7Chapter
8Chapter
9Chapter
10Chapter
>Next
11Chapter
12Chapter
13Chapter
14Chapter
15Chapter
16Chapter
17Chapter
18Chapter
19Chapter
<Previous

Chapter 9Associates and joint arrangements

  • 9.5Movement analysis of investments in associates and joint ventures
      Group 
      Associates     Joint ventures     Total equity-accounted
investments
 
At 31 December  Note  2024 
Rm
 
2023 
Rm 
   2024 
Rm 
2023 
Rm 
   2024 
Rm 
2023 
Rm 
Gross carrying amount                     
At beginning of the year    18 971  15 676     1 922  2 999     20 893  18 675 
Net share of results    4 041  6 470     226  448     4 267  6 918 
– Share of income  9.3  4 036  6 479     234  508     4 270  6 987 
– Elimination of movement in unrealised profit    (9)    (8) (60)    (3) (69)
Dividends received1    (3 741) (3 386)    (130) (1 525)    (3 871) (4 911)
Share of movement in reserves    (78) 211              (78) 211 
At end of the year     19 193  18 971     2 018  1 922     21 211  20 893 
Accumulated impairment                        
At beginning of the year    (615) (615)         (615) (615)
At end of the year2     (615) (615)          (615) (615)
Net carrying amount at end of the year     18 578  18 356     2 018  1 922     20 596  20 278 
1 Relates to: SIOC of R3 741 million (2023: R3 386 million) and Mafube of R130 million (2023: R1 525 million).
2 Accumulated impairments relate to: GAM R58 million, Insect Technology R504 million and LightApp R53 million.